Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 8, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 19 January 2026 - 16:39

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 8, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/xenpozyme

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters